AaronSMansfieldMD

PubMed

• Ki-67 Proliferation Index Is Associated With Tumor Grade and Survival in Pleural Epithelioid Mesotheliomas.
  Belinda Galeano, Caleb J Smith, Eunhee S Yi, Anja C Roden, Sarah Jenkins, Jenna Capelle, Mary Kittle-Francis, Aaron S Mansfield, Marie Christine Aubry> ;The American Journal of Surgical Pathology. 2024 May 1
• Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
  Vivek Subbiah, Mimi I Hu, Aaron S Mansfield, Matthew H Taylor, Martin Schuler, Viola W Zhu, Julien Hadoux, Giuseppe Curigliano, Lori Wirth, Justin F Gainor, Guzman Alo...> ;Thyroid. 2024 Jan 1
• 1 citations
  The Timing, Trajectory, and Incidence of Immune-Related Adverse Events in NSCLC Treated With Atezolizumab.
  Pritzl, S., Yu, W., Bara, I., Kaul, M., Williams, K., Dueck, A., Smith, K., Thanarajasingam, G., Mansfield, A.> ;JTO Clinical and Research Reports. 2023 Dec 1
• Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8T cells via ME1 up-regulation.
  Joanina K Gicobi, Zhiming Mao, Grace DeFranco, Jacob B Hirdler, Ying Li, Vianca V Vianzon, Emilia R Dellacecca, Michelle A Hsu, Whitney Barham, Yiyi Yan, Aaron S Mansf...> ;Science Advances. 2023 Nov 17
• Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).
  Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, Melina E Marmarelis, Carolyn J Presley, Karen L Reckamp, Hina Khan, Mary Jo Fidler, Christine M Bestvina, Julie Brahm...> ;Lung Cancer. 2023 Dec 1
• Capmatinib-Associated Pseudoacute Kidney Injury in Nonsmall Cell Lung Cancer.
  Leticia Sandoval, Yeshwanter Radhakrishnan, Lisa E Vaughan, Ashley Potter, Aaron S Mansfield, Sandra M Herrmann> ;Kidney International Reports. 2023 Nov 1
• Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and et...
  Stephen V Liu, Tony S K Mok, Barzin Y Nabet, Aaron S Mansfield, Richard De Boer, György Losonczy, Shunichi Sugawara, Rafal Dziadziuszko, Maciej Krzakowski, Alexey Smol...> ;Lung Cancer. 2023 Dec 1
• 4 citations
  Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.
  Aakash Desai, Caleb J Smith, Yash Ashara, Jacob J Orme, Saurabh Zanwar, Ashley Potter, Craig Hocum, J Nicole Moffett, Anna J Schwecke, Rami Manochakian, Yanyan Lou, Yu...> ;Clinical Lung Cancer. 2023 Dec 1
• 2 citations
  Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.
  Jürgen Wolf, Pierre-Jean Souquet, Koichi Goto, Alexis Cortot, Christina Baik, Rebecca Heist, Tae Min Kim, Ji-Youn Han, Joel W Neal, Aaron S Mansfield, Isabelle Gillote...> ;Clinical Lung Cancer. 2023 Nov 1
• 5 citations
  Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report.
  Aakash Desai, Sagar Rakshit, Radhika Bansal, Yash Ashara, Ashley Potter, Rami Manochakian, Yanyan Lou, Yujie Zhao, Vinicius Ernani, Panos Savvides, Anna Schwecke, Nico...> ;Cancer Treatment and Research Communications. 2023 Jan 1
• Dynamics and survival associations of T cell receptor clusters in patients with pleural mesothelioma treated with immunotherapy.
  Aakash P Desai, Farhad Kosari, Maria Disselhorst, Jun Yin, Alireza Agahi, Tobias Peikert, Julia Udell, Sarah H Johnson, James Smadbeck, Stephen Murphy, Giannoula Karag...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• Epigenomics may begin to explaindifferential response to hypomethylating agents in MMR-D hypermethylated endometrial cancer.
  El Khoury, L., Lin, W., Smadbeck, J., Barrett, M., Sadeghian, D., McCune, A., Karagouga, G., Cheville, J., Harris, F., Kinsella, L., Feathers, R., Schafer Klein, J., W...> ;Epigenomics. 2023 Mar 1
• 1 citations
  A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 Inhibitors.
  Whitney Barham, Michelle Hsu, Xin Liu, Susan M Harrington, Jacob B Hirdler, Joanina K Gicobi, Xingxing Zhu, Hu Zeng, Kevin D Pavelko, Yiyi Yan, Aaron S Mansfield, Haid...> ;Immunohorizons. 2023 Jan 1
• 2 citations
  Small Cell Transformation in a Patient WithFusion-Positive Lung Adenocarcinoma on Pralsetinib.
  Anastasios Dimou, Ying-Chun Lo, Kenneth W Merrell, Kevin C Halling, Aaron S Mansfield> ;JCO Precision Oncology. 2022 Dec 1
• 2 citations
  Clinical Utility Validation of an Automated Ultrarapid Gene Fusion Assay for NSCLC.
  Alessia Buglioni, Patricia L Caffes, Mark G Hessler, Aaron S Mansfield, Ying-Chun Lo> ;JTO Clinical and Research Reports. 2022 Dec 1
• 9 citations
  Perioperative Immune Checkpoint Inhibition in Early-Stage Non-Small Cell Lung Cancer: A Review.
  Aakash P Desai, Jacob J Adashek, Joshua E Reuss, Howard Jack West, Aaron S Mansfield> ;JAMA Oncology. 2023 Jan 1
• 18 citations
  Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology.
  James M Dolezal, Andrew Srisuwananukorn, Dmitry Karpeyev, Siddhi Ramesh, Sara Kochanny, Brittany Cody, Aaron S Mansfield, Sagar Rakshit, Radhika Bansal, Melanie C Bois...> ;Nature Communications. 2022 Nov 2
• 43 citations
  Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial.
  F Griesinger, G Curigliano, M Thomas, V Subbiah, C S Baik, D S W Tan, D H Lee, D Misch, E Garralda, D-W Kim, A J van der Wekken, J F Gainor, L Paz-Ares, S V Liu, G P K...> ;Annals of Oncology. 2022 Nov 1
• 1 citations
  Lower Exome Sequencing Coverage of Ancestrally African Patients in The Cancer Genome Atlas.
  Daniel P Wickland, Mark E Sherman, Derek C Radisky, Aaron S Mansfield, Yan W Asmann> ;Journal of the National Cancer Institute. 2022 Aug 8
• Response to Mitr and Pollack.
  Daniel P Wickland, Mark E Sherman, Derek C Radisky, Aaron S Mansfield, Yan W Asmann> ;Journal of the National Cancer Institute. 2022 Dec 8
• 24 citations
  Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
  Michele Carbone, Harvey I Pass, Guntulu Ak, H Richard Alexander Jr, Paul Baas, Francine Baumann, Andrew M Blakely, Raphael Bueno, Aleksandra Bzura, Giuseppe Cardillo, ...> ;Journal of Thoracic Oncology. 2022 Jul 1
• 3 citations
  Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide.
  Martin Reck, Tony S K Mok, Aaron Mansfield, Richard De Boer, Gyorgy Losonczy, Shunichi Sugawara, Rafal Dziadziuszko, Maciej Krzakowski, Alexey Smolin, Maximilian Hochm...> ;Journal of Thoracic Oncology. 2022 Sep 1
• 1 citations
  The Evolving Therapeutic Landscape for Malignant Pleural Mesothelioma.
  Nirosha D Perera, Aaron S Mansfield> ;Current Oncology Reports. 2022 Nov 1
• 7 citations
  Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy.
  Pedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, Gehan Botrus, Mohamad Bassam Sonbol, Daniel H Ahn, Jason S Starr, Jeremy C Jones, Hani Babiker, Samantha R Inabi...> ;JCO Precision Oncology. 2022 Jun 1
• 2 citations
  Validating chemoimmunotherapy in small-cell lung cancer.
  Katherine E R Smith, Aaron S Mansfield> ;The Lancet. Oncology. 2022 Jun 1
• Join now to see all

Journal Articles

• Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis  
  Phan M, John S, Casanegra AI, Rathbun S, Mansfield A, Stoner JA, Tafur AJ, J Thromb Thrombolysis, 1/1/2014
• Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials  
  Mansfield AS, Symanowski JT, Peikert T, Lung Cancer, 1/1/2014

Books/Book Chapters

• The 5-minute clinical consult 
  Chapter: von Willebrand Disease 
  Page 1420 - 1421Mansfield ASEditors: Domino FJ.Lippincott Williams & Wilkins, Philadelphia, PA2010

Abstracts/Posters

• Programmed cell death 1 ligand 1 expression and association with survival in mesothelioma
  Mansfield AS, Peikert T, Roden A, Krco C, Harrington S, Dong H, Kwon E, Thorac Oncol, 1/1/2014
• Immune cell profile of the sln has prognostic value in stage iii melanoma
  Grotz TE, Mansfield AS, Jakub JW, Markovic SN, Hieken TJ, Cancer Res, 1/15/2013
• Dna methylation and expression patterns in adenocarcinomas of the lung of never-smokers with discordant methylation and expression patterns of homeobox related genes
  Mansfield AS, Wang L, Cunningham JM, Jen J, Kolbert C, Sun ZF, Yang P, J Thorac Oncol, 1/1/2013
• Immunologic changes in patients with metastatic melanoma on bevacizumab and chemotherapy versus chemotherapy alone
  Mansfield AS, Nevala WK, Markovic SN, Journal of Clinical Oncology, 1/1/2012
• Aging is associated with an increase in regulatory T cells, MCP-1 and RANTES
  Mansfield A, Nevala W, Dronca R, Leontovich A, Markovic S, J Immunol, 1/1/2012
• Aging is associated with an increase in TH2 cells, MCP-1 and RANTES
  Mansfield AS, Immunology (American Association of Immunologists), Boston, MA, 1/1/2012
• Effects of bevacizumab on systemic immunity in the treatment of metastatic
  Mansfield AS, ASCO Markers in Cancer, Hollywood, FL, 1/1/2012
• Skin surveillance and malignancies in patients with chronic lymphocytic leukemia
  Mansfield AS, ASCO Quality Care Symposium, San Diego, CA, 1/1/2012
• Comparison on fluorescence in situ hybridization and dual-in situ hybridization in the determination of HER2 status in breast cancer
  Mansfield AS, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2012
• Regional Immunity in Melanoma: Immunosuppressive Changes Precede Nodal Metastasis
  Mansfield AS, Holtan SG, Grotz TE, Allred JB, Jakub JW, Erickson LA, Flotte TJ, Markovic SN, Journal of Clinical Oncology, 1/1/2010
• Using fetomaternal interactions to identify immunomodulatory mechanisms in melanoma
  Holtan SG, Mansfield AS, Creedon DJ, Nevala WK, Leontovich AA, Markovic SN, Placenta, 1/1/2010
• Regional Immunity in Melanoma: Immunosuppressive Changes Precede Nodal Metastasis
  Mansfield AS, ASCO, Chicago, IL, 1/1/2010
• Mayo Clinic experience with rare exocrine pancreatic neoplasms
  Mansfield AS, ASCO Gastrointestinal Cancers Symposium, 1/1/2010
• Topical peptide immunization with NY-ESO-1B peptide (SLLMWITQC) using resiquimod as an immune djuvant
  Mansfield A, Kottschade L, McWilliams R, Creagan E, Kaur J, Croghan G, Quevedo F, Markovic S, J Immunother, 1/1/2009
• Regional Immunity in Melanoma
  Mansfield AS, NIH Frontiers in Basic Immunology, Bethesda, MD, 1/1/2009
• VEGF-C in association with VEGFR-3 promotes nodal metastases in breast cancer with extensive intraductal component
  Van Iterson, Heikkila P, Mansfield AS, von Smitten K, Leidenius M, European Journal of Cancer, 1/1/2008
• VEGF-C in association with VEGFR-3 promotes nodal metastases in breast cancer with extensive intraductal component
  Mansfield AS, 6th European Breast Cancer Conference, Berlin, Germany, 1/1/2008
• Swallowing Systole
  Mansfield AS, Society of General Internal Medicine Midwest meeting, Chicago, IL, 1/1/2008
• Reproductive assistance gone amiss: Pulmonary embolism in a 30 year-old female with ovarian hyperstimulatory syndrome
  Mansfield AS, Society of General Internal Medicine Mountain West meeting, Tempe, AZ, 1/1/2008
• Lost in Translation: 47 year-old gentleman with sound-induced vertigo
  Mansfield AS, American College of Physicians Minnesota chapter meeting, Minneapolis, MN, 1/1/2008
• Decreased accumulation of CD163-positive macrophages is associated with nodal metastases in patients with breast cancer
  Mansfield AS, Heikkila P, Vakkila J, von Smitten K, Leidenius M, Breast Cancer Research and Treatment, 1/1/2007
• Decreased accumulation of CD163-positive macrophages is associated with nodal metastases in patients with breast cancer
  Mansfield AS, 30th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2007
• Spontaneous episodic hypothermia with hyperhidrosis in a patient with HIV-1
  Mansfield AS, American College of Physicians Minnesota Chapter Scientific Meeting, Minneapolis, MN, 1/1/2007
• Foxp3-positive regulatory T cells are associated with nodal stratus in breast cancer
  Mansfield AS, Vakkila J, Heikkila P, von Smitten K, Leidenius M, Journal of Immunotherapy, 1/1/2006
• Foxp3-positive regulatory T cells are associated with nodal stratus in breast cancer
  Mansfield AS, Heikkila P, Vakkila J, von Smitten K, Leidenius M, Breast Cancer Research and Treatment, 1/1/2006
• Join now to see all

Lectures

• Identifying Appropriate Trials for Our Patients and Considering Compassionate Use Programs 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• LB-100: Rethinking protein phosphorylation 
  Santa Monica, CA - 1/1/2014
• Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials 
  Cape Town, South Africa (2014); Perth, Australia (2014) - 1/1/2014
• The Potential of Immune Checkpoint Inhibition in Mesothelioma 
  Perth, Australia - 1/1/2014
• Programmed Cell Death 1 Ligand 1 Expression and Association with Survival in Mesothelioma 
  Geneva, Switzerland - 1/1/2014
• Lung Cancer Updates 
  Denver, CO - 1/1/2014
• Melanoma Peptide Vaccines: Lessons in Immunosuppression 
  Beijing, China - 1/1/2012
• Regional Immunity in Melanoma 
  Indianapolis, IN - 1/1/2011
• Treating Chronic Myeloid Leukemia in Nepal: Cytogenetic techniques and result interpretation 
  Patan, Nepal - 1/1/2011
• Join now to see all